Page last updated: 2024-11-03

1,2,5,8-tetrahydroxy anthraquinone and Amyloid Neuropathies, Familial

1,2,5,8-tetrahydroxy anthraquinone has been researched along with Amyloid Neuropathies, Familial in 1 studies

1,2,5,8-tetrahydroxy anthraquinone: structure in first source
quinalizarin : A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.

Amyloid Neuropathies, Familial: Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kitakami, R1
Inui, K1
Nakagawa, Y1
Sawai, Y1
Katayama, W1
Yokoyama, T1
Okada, T1
Kanamitsu, K1
Nakagawa, S1
Toyooka, N1
Mizuguchi, M1

Other Studies

1 other study available for 1,2,5,8-tetrahydroxy anthraquinone and Amyloid Neuropathies, Familial

ArticleYear
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
    Bioorganic & medicinal chemistry, 2021, 08-15, Volume: 44

    Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship,

2021